Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2016 | Research article

Antidiabetic and hypolipidemic activities of hydroethanolic root extract of Uvaria chamae in streptozotocin induced diabetic albino rats

Authors: Jonathan Emeka Emordi, Esther Oluwatoyin Agbaje, Ibrahim Adekunle Oreagba, Osede Ignis Iribhogbe

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

Diabetes mellitus is a metabolic disorder of multiple aetiology characterised by hyperglycemia resulting from defects in insulin secretion, insulin action or both. It is a global epidemic ravaging both developed and developing countries. The situation will worsen if nothing is done urgently. In fact, the need to identify natural products with antidiabetic potentials is of great importance as supported by several research efforts all over the world, in search of antidiabetic plant based products that are safe and efficacious. Available literatures show that several phytochemicals with antidiabetic properties have been identified in certain plants amongst which include Uvaria chamae. The potentials of Uvaria chamae as an antidiabetic and hypolipidemic drug-candidate are thus tested.

Methods

Diabetes mellitus was experimentally induced after the rats were fasted overnight by administering intraperitoneally, 60 mg/kg streptozotocin. After 72 h, the rats with plasma glucose levels >200 mg/dl were classified as diabetic. A total of six groups containing five rats per group were used. One group of diabetic rats was untreated. Three diabetic groups, each were treated orally with 100, 250 and 400 mg/kg body weight of the extract. Another diabetic group was treated with insulin (0.5 IU/kg) subcutaneously. The control received 0.5 ml (2% solution) of acacia orally. The treatment was for 8 days. The effects of the extract on weight, plasma glucose and other biochemical parameters were evaluated using standard procedures.

Results

The diabetic rats treated with the extract showed significant reductions (p < 0.05) in weight, plasma glucose levels, low density lipoprotein and cholesterol compared with the control. The 100, 250 and 400 mg/kg body weight of the extract showed maximum glucose reduction of 85.16, 81.50 and 86.02% respectively. Histologically the pancreas of the diabetic rats treated with the extract, showed clusters of variably sized regenerated islet of Langerhans within sheets of normal exocrine pancreas, while the pancreas of diabetic rats treated with insulin showed no islet of Langerhans.

Conclusion

The study showed that Uvaria chamae caused weight loss and has good hypoglycemic and hypolipidemic activities that may reduce the risk of developing cardiovascular diseases.
Literature
1.
go back to reference Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefPubMed Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.CrossRefPubMed
2.
go back to reference Kumar P, Clark M. Diabetes mellitus and other disorders of metabolism. Kumar and Clark’s Clinical Medicine. 6th ed. Philadelphia: Elsevier Saunders; 2005. p. 1101–51. Kumar P, Clark M. Diabetes mellitus and other disorders of metabolism. Kumar and Clark’s Clinical Medicine. 6th ed. Philadelphia: Elsevier Saunders; 2005. p. 1101–51.
3.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of Diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of Diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed
5.
go back to reference Martin-Timon I, Sevillano-Collantes C, Segura-Galindo A, del Canizo-Gomez FJ. Type2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014;5:444–70.CrossRefPubMedPubMedCentral Martin-Timon I, Sevillano-Collantes C, Segura-Galindo A, del Canizo-Gomez FJ. Type2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014;5:444–70.CrossRefPubMedPubMedCentral
6.
7.
go back to reference Mallick C, Chatterjee K, GuhaBiswas M, Ghosh D. Antihyperglycemic effects of separate and composite extract of root of Musa paradisiacaand leaf of Cocciniaindicain streptozotocin induced diabetic male albino rat. Afr J Tradit Complement Altern Med. 2007;4:362–71.CrossRefPubMedPubMedCentral Mallick C, Chatterjee K, GuhaBiswas M, Ghosh D. Antihyperglycemic effects of separate and composite extract of root of Musa paradisiacaand leaf of Cocciniaindicain streptozotocin induced diabetic male albino rat. Afr J Tradit Complement Altern Med. 2007;4:362–71.CrossRefPubMedPubMedCentral
9.
go back to reference Emordi JE, Agbaje EO, Oreagba IA, Iribhogbe OI. Preliminary phytochemical screening and evaluation ofhypoglycemic properties of the root extract of Uveriachamae. Bangladesh J Pharmacol. 2015;10:326–31.CrossRef Emordi JE, Agbaje EO, Oreagba IA, Iribhogbe OI. Preliminary phytochemical screening and evaluation ofhypoglycemic properties of the root extract of Uveriachamae. Bangladesh J Pharmacol. 2015;10:326–31.CrossRef
10.
go back to reference Okwu DE, Iroabuchi F. Phytochemical Composition and Biological Activities of Uvariachamae and Clerodendoronsplendens. E-J Chem. 2009;6:553–60.CrossRef Okwu DE, Iroabuchi F. Phytochemical Composition and Biological Activities of Uvariachamae and Clerodendoronsplendens. E-J Chem. 2009;6:553–60.CrossRef
11.
go back to reference Okwuosa OM, Chukwura EI, Chukwuma GO, Okwuosa CN, Enweani IB, Agbakoba NR, et al. Phytochemical and antifungal activities of Uvaria Chamae leaves and roots, spondiasmombin leaves and bark and combretumracemosum leaves. Afr J Med Med Sci. 2012;41(suppl):99–103.PubMed Okwuosa OM, Chukwura EI, Chukwuma GO, Okwuosa CN, Enweani IB, Agbakoba NR, et al. Phytochemical and antifungal activities of Uvaria Chamae leaves and roots, spondiasmombin leaves and bark and combretumracemosum leaves. Afr J Med Med Sci. 2012;41(suppl):99–103.PubMed
12.
go back to reference Osuagwu GGE, Ihenwosu AO. Phytochemical Composition and Antimicrobial Activity of the Leaves of Alchorneacordifolia (Schum and Thonn), Sansevieraliberica (GerandLabr) and Uvariachamae (P. Beauv). Am J Phytomed Clin Therap. 2014;2:1–12. Osuagwu GGE, Ihenwosu AO. Phytochemical Composition and Antimicrobial Activity of the Leaves of Alchorneacordifolia (Schum and Thonn), Sansevieraliberica (GerandLabr) and Uvariachamae (P. Beauv). Am J Phytomed Clin Therap. 2014;2:1–12.
13.
go back to reference Okokon JE, Ita BN, Udokpo AE. The invivo antimalarial activities of uvariachamae and hippocratea Africana. Ann Trop Med and Parasitol. 2006;100:585–90.CrossRef Okokon JE, Ita BN, Udokpo AE. The invivo antimalarial activities of uvariachamae and hippocratea Africana. Ann Trop Med and Parasitol. 2006;100:585–90.CrossRef
14.
go back to reference Adelodun VO, Elusiayan CA, Olorunmola FO, Adewoyin FB, Omisore NO, Adepiti AO, Agbedahunsi JM, Adewunmi CO. Afr J Tradit Complement Altern Med. 2013;10:469–76.CrossRefPubMedPubMedCentral Adelodun VO, Elusiayan CA, Olorunmola FO, Adewoyin FB, Omisore NO, Adepiti AO, Agbedahunsi JM, Adewunmi CO. Afr J Tradit Complement Altern Med. 2013;10:469–76.CrossRefPubMedPubMedCentral
15.
go back to reference National Research Council (NRC). Guide for the care and use of laboratory animals. 8th ed. Washington, DC: The National Academies Press; 2011. National Research Council (NRC). Guide for the care and use of laboratory animals. 8th ed. Washington, DC: The National Academies Press; 2011.
16.
go back to reference Srinivasan K, Ramarao P. Animal models in type2 diabetes research: an overview. Indian J Med Res. 2007;125:451–72.PubMed Srinivasan K, Ramarao P. Animal models in type2 diabetes research: an overview. Indian J Med Res. 2007;125:451–72.PubMed
17.
go back to reference Qinna NA, Badwan AA. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des Devel Ther. 2015;9:2515–25.CrossRefPubMedPubMedCentral Qinna NA, Badwan AA. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des Devel Ther. 2015;9:2515–25.CrossRefPubMedPubMedCentral
18.
go back to reference Wasan KM, Najafi S, Wong J, Kwong M, Pritchard PH. Assessing plasma lipid levels, body weight and hepatic and renal toxicity following chronic oral administration of a water soluble phytostanol compound FM-VP4, to gerbils. J Pharm Pharm Sci. 2001;4:228–34.PubMed Wasan KM, Najafi S, Wong J, Kwong M, Pritchard PH. Assessing plasma lipid levels, body weight and hepatic and renal toxicity following chronic oral administration of a water soluble phytostanol compound FM-VP4, to gerbils. J Pharm Pharm Sci. 2001;4:228–34.PubMed
19.
go back to reference Crook MA. Clinical Chemistry and Metabolic Medicine. 7th ed. London: Hodder Arnold; 2006. Crook MA. Clinical Chemistry and Metabolic Medicine. 7th ed. London: Hodder Arnold; 2006.
20.
go back to reference Horder M, Sampson EJ. Approved IFCC recommendation on methods for the measurement of catalytic concentration of enzymes Part 7: IFCC method for creatinine Kinase (ATP: Creatine N-phosphotransferase, EC. 2. 7. 3. 2). Eur J Clin Chem Clin Biochem. 1991;29:435–56.PubMed Horder M, Sampson EJ. Approved IFCC recommendation on methods for the measurement of catalytic concentration of enzymes Part 7: IFCC method for creatinine Kinase (ATP: Creatine N-phosphotransferase, EC. 2. 7. 3. 2). Eur J Clin Chem Clin Biochem. 1991;29:435–56.PubMed
21.
go back to reference Hussain A, Eshrat HM. Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma longa, Linn and partially purified product from Abromaaugusta, Linn. in streptozotocin induced diabetes. Indian J Clin Biochem. 2002;17:33–43.CrossRef Hussain A, Eshrat HM. Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma longa, Linn and partially purified product from Abromaaugusta, Linn. in streptozotocin induced diabetes. Indian J Clin Biochem. 2002;17:33–43.CrossRef
22.
go back to reference Grizzle WE, Fredenburgh JL, Myers RB. Fixation of tissues. In: Bancroft JD, Gamble M, editors. Theory and practice of Histological techniques. 6th ed. Philadelphia: Churchill Livingstone, Elsevier Limited; 2008. p. 53–74.CrossRef Grizzle WE, Fredenburgh JL, Myers RB. Fixation of tissues. In: Bancroft JD, Gamble M, editors. Theory and practice of Histological techniques. 6th ed. Philadelphia: Churchill Livingstone, Elsevier Limited; 2008. p. 53–74.CrossRef
23.
go back to reference Sarkar S, Balhara Y. Diabetes mellitus and Suicide. Indian J Endocrinology Met. 2014;18:468–74.CrossRef Sarkar S, Balhara Y. Diabetes mellitus and Suicide. Indian J Endocrinology Met. 2014;18:468–74.CrossRef
24.
go back to reference Nordestgaard BG, Stender S, Kjeldsen K. Reduces artherogenesis in cholesterol fed Diabetic rabbits. Giant lipoproteins do not enter the arterial wall. Arterioscler. 1988;8:421–8.CrossRef Nordestgaard BG, Stender S, Kjeldsen K. Reduces artherogenesis in cholesterol fed Diabetic rabbits. Giant lipoproteins do not enter the arterial wall. Arterioscler. 1988;8:421–8.CrossRef
25.
go back to reference Barrett- Connor EL, Cohn BA, Wingard DL Edelstein SL. Why is Diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in man ? The Rancho Bernardo study. JAMA. 1991;265:627–31.CrossRefPubMed Barrett- Connor EL, Cohn BA, Wingard DL Edelstein SL. Why is Diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in man ? The Rancho Bernardo study. JAMA. 1991;265:627–31.CrossRefPubMed
26.
go back to reference Park JM, Bong HY, Jeong HI, Kim YK, Kim JY, Kwon O. Postprandial hypoglycemic effect of mulberry leaves in Gotokakizaki rats and counterpart control Wistar rats. Nutr Res Pract. 2009;3:272–8.CrossRefPubMedPubMedCentral Park JM, Bong HY, Jeong HI, Kim YK, Kim JY, Kwon O. Postprandial hypoglycemic effect of mulberry leaves in Gotokakizaki rats and counterpart control Wistar rats. Nutr Res Pract. 2009;3:272–8.CrossRefPubMedPubMedCentral
27.
go back to reference Jacobson TA, Miller M, Schaefer EJ. Hypertriglyceridemia and cardiovascular risk reduction. ClinTher. 2007;29:763–77. Jacobson TA, Miller M, Schaefer EJ. Hypertriglyceridemia and cardiovascular risk reduction. ClinTher. 2007;29:763–77.
28.
go back to reference Heidrich JE, Contos LM, Hunsaker LA, Deck LM, Vander Jagt DL. Inhibition of pancreatic cholesterase reduces cholesterol absorption in the hamster. BMC Pharmacol. 2004; doi: 10.1186/1471-2210-4-5 Heidrich JE, Contos LM, Hunsaker LA, Deck LM, Vander Jagt DL. Inhibition of pancreatic cholesterase reduces cholesterol absorption in the hamster. BMC Pharmacol. 2004; doi: 10.​1186/​1471-2210-4-5
29.
go back to reference Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 2007;12:879–89.CrossRefPubMed Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 2007;12:879–89.CrossRefPubMed
30.
go back to reference Gotto Jr AM, Grundy SM. Lowering LDL Cholesterol: Questions From Recent Meta-Analyses and Subset Analyses of Clinical Trial Data Issues From the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, Ninth Council Meeting. Circulation. 1999;99:1–7.CrossRef Gotto Jr AM, Grundy SM. Lowering LDL Cholesterol: Questions From Recent Meta-Analyses and Subset Analyses of Clinical Trial Data Issues From the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, Ninth Council Meeting. Circulation. 1999;99:1–7.CrossRef
31.
go back to reference Kashyap SR, Defronzo RA. The Insulin resistance syndrome: physiological considerations. Diabetes Vasc Dis Res. 2007;4:13–9.CrossRef Kashyap SR, Defronzo RA. The Insulin resistance syndrome: physiological considerations. Diabetes Vasc Dis Res. 2007;4:13–9.CrossRef
32.
go back to reference William M, Stephen B. The kidneys. Clinical chemistry. 6th ed. Philadephia: Mosby Elsevier; 2008. p. 69–93. William M, Stephen B. The kidneys. Clinical chemistry. 6th ed. Philadephia: Mosby Elsevier; 2008. p. 69–93.
33.
go back to reference Lamb E, Neuwman DJ, Price C. Kidney function tests. In: Burtis CA, Ashwood ER, Burns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. Philadelphia: Elsevier Saunders; 2006. p. 797–835. Lamb E, Neuwman DJ, Price C. Kidney function tests. In: Burtis CA, Ashwood ER, Burns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. Philadelphia: Elsevier Saunders; 2006. p. 797–835.
34.
go back to reference Parvizi MR, Parviz M, Tavangar SM, Soltani N, Kadkhodaee M, Seifi B, et al. Protective effect of magnesium on renal function in STZ-induced diabetic rats. J DiabetMetab Dis. 2014;13:84. Parvizi MR, Parviz M, Tavangar SM, Soltani N, Kadkhodaee M, Seifi B, et al. Protective effect of magnesium on renal function in STZ-induced diabetic rats. J DiabetMetab Dis. 2014;13:84.
35.
go back to reference Panteghini M, Bais R, van Solinge WW. Enzymes. In: Burtis CA, Ashwood ER, Burns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. Philadelphia: Elsevier Saunders; 2006. p. 597–643. Panteghini M, Bais R, van Solinge WW. Enzymes. In: Burtis CA, Ashwood ER, Burns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. Philadelphia: Elsevier Saunders; 2006. p. 597–643.
36.
go back to reference Senior JR. Monitoring for hepatotoxicity: what is the predictive value of liver “function” tests? Clin Pharmacol Ther. 2009;85:331–4.CrossRefPubMed Senior JR. Monitoring for hepatotoxicity: what is the predictive value of liver “function” tests? Clin Pharmacol Ther. 2009;85:331–4.CrossRefPubMed
37.
go back to reference Coates P. Liver function tests. Aust Fam Physician. 2011;40:113–5.PubMed Coates P. Liver function tests. Aust Fam Physician. 2011;40:113–5.PubMed
38.
go back to reference Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut. 1999;45:129–33.CrossRefPubMedPubMedCentral Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut. 1999;45:129–33.CrossRefPubMedPubMedCentral
39.
go back to reference Harris EH. Elevated liver function tests in type 2 diabetes. Clin Diabetes. 2005;23:115–9.CrossRef Harris EH. Elevated liver function tests in type 2 diabetes. Clin Diabetes. 2005;23:115–9.CrossRef
40.
go back to reference Leeds JS, Forman EM, Morley S, Scott AR, Tesfaye S, Sanders DS. Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabetes Med. 2009;26:1235–41.CrossRef Leeds JS, Forman EM, Morley S, Scott AR, Tesfaye S, Sanders DS. Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabetes Med. 2009;26:1235–41.CrossRef
41.
go back to reference Hollander P. Anti-Diabetes and Anti-Obesity Medications: Effects on Weight in People with Diabetes. Diabetes Spectrum. 2007;20:159–65.CrossRef Hollander P. Anti-Diabetes and Anti-Obesity Medications: Effects on Weight in People with Diabetes. Diabetes Spectrum. 2007;20:159–65.CrossRef
Metadata
Title
Antidiabetic and hypolipidemic activities of hydroethanolic root extract of Uvaria chamae in streptozotocin induced diabetic albino rats
Authors
Jonathan Emeka Emordi
Esther Oluwatoyin Agbaje
Ibrahim Adekunle Oreagba
Osede Ignis Iribhogbe
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1450-0

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue